Skip to main content
SpringerLink
Log in

Vascular Dopamine and Dopamine Receptor Agonists

  • Chapter
Dopamine Receptor Agonists

Part of the book series: New Horizons in Therapeutics ((NHTH))

Abstract

Regulation and modulation of the sympathetic nervous system have been and remain cornerstone strategies for the treatment of cardiovascular disease. Whereas stimulating, mimicking or antagonizing norepinephrine and epinphrine have been the most frequently utilized approach to cardiovascular renal therapeutics, the possibility that dopamine and dopamine receptors serve as useful target sites for drug action has received less attention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ackerman, D. M., Weinstock, J. Wiebelhaus, V. D., and Berkowitz, B., 1982, Renal vasodilators and hypertension, Drug Dev. Res. 2:283–297.

    Article  CAS  Google Scholar 

  • Bell, C, and Lang, W., 1982, Is there a place for dopamine in autonomic neuromuscular transmission: in: Trends in Autonomic Pharmacology, Volume 2 (Stanley Kalsner, ed.), Urban & Schwarzenberg, Baltimore, pp. 263–282.

    Google Scholar 

  • Berkowitz, B. A., 1983, Dopamine and dopamine receptors as target sites for cardiovascular drug action, Fed. Proc. 42:3019–3021.

    PubMed  CAS  Google Scholar 

  • Brodde, O.-E., 1982, Vascular dopamine receptors: Demonstration and characterization by in vitro studies, Life Sci. 31:289–306.

    Article  PubMed  CAS  Google Scholar 

  • Brodde, O.-E., and Gross, G., 1980 (3H]-Spiroperidol labels dopamine receptors in membranes from rabbit mesenteric artery, Naunyn Schmiedebergs Arch. Pharmacol. 311:249–254.

    Article  PubMed  CAS  Google Scholar 

  • Brodde, O.-E., and Meyer, F.-J., 1979, On the existence of vascular dopamine receptors on the isolated rabbit mesenteric artery, Naunyn Schmiedebergs Arch Pharmacol. 308(Suppl):R56.

    Google Scholar 

  • Brodde, O.-E., and Schemuth, W., 1979, Specific antagonism by metoclopramide of dopamine induced relaxation on isolated rabbit mesenteric arteries contracted with prostaglandin F2α, Life Sci. 25:23–30.

    Article  PubMed  CAS  Google Scholar 

  • Brodde, O.-E., Freistühler, J., and Meyer, F.-J., 1981a, Stereospecific antagonism by d-Butaclamol of dopamine-induced relaxation of the isolated rabbit mesenteric artery, J. Cardiovasc. Pharmacol. 3:828–837.

    Article  CAS  Google Scholar 

  • Brodde, O.-E., Meyer, F.-J., Schemuth, W., and Freistühler, J., 1981b, Demonstration of specific vascular dopamine receptors mediating vasodilation on the isolated rabbit mesenteric artery, Naunyn Schmiedebergs Arch. Pharmacol. 316:24–30.

    Article  CAS  Google Scholar 

  • Brown, R. A., O’Connor, S. E., Smith, G. W., and Verity, A., 1983, The rabbit isolated arterially perfused intestinal segment preparation: A model for vascular dopamine receptors, J. Pharmacol. Methods. 9:137–145.

    Article  PubMed  CAS  Google Scholar 

  • Cavero, J., Massingham, R., and Lefevre-Borg, F., 1982, Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents, Part I: SubClassification and functional description, Life Sci. 31:939–948.

    Article  PubMed  CAS  Google Scholar 

  • Crooks, R. J., and Martin, G. R., 1979, An isolated vascular tissue preparation showing a specific relaxant effect of dopamine, Br. J. Pharmacol. 67:474P.

    Google Scholar 

  • Forster, C, and Whalley, E. T., 1981, Dopamine receptors mediating relaxation of the human basilar artery in vitro, Br. J. Pharmacol. 74:944P–945P.

    Google Scholar 

  • Forster, C, Drew, G. M., Hilditch, A., and Whalley, E. T., 1983, Dopamine receptors in human basilar arteries, Eur. J. Pharmacol. 87:227–235.

    Article  PubMed  CAS  Google Scholar 

  • Furchgott, R. F., and Zawadzki, J. V., 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature 288:373–376.

    Article  PubMed  CAS  Google Scholar 

  • Goldberg, L. I., 1972, Cardiovascular and renal actions of dopamine: Potential clinical application, Pharmacol. Rev. 24:1–29.

    PubMed  CAS  Google Scholar 

  • Goldberg, L. I., and Kohli, J. D., 1979, Peripheral pre-and post-synaptic dopamine receptors: Are they different from dopamine receptors in the central nervous system? Commun. Psychopharmacol. 3:447–456.

    PubMed  CAS  Google Scholar 

  • Goldberg, L. I., and Kohli, J. D., 1983, Peripheral dopamine receptors: A classification based on potency series and specific antagonism, Trends Pharmacol. 4:64–66.

    Article  CAS  Google Scholar 

  • Goldberg, L. I., and Toda, N., 1975, Dopamine induced relaxation of isolated canine renal, mesenteric and femoral arteries contracted with Prostaglandin F2α, Circ. Res. 36(Supp. I):97–102.

    Article  PubMed  CAS  Google Scholar 

  • Goldberg, L. I., Volkman, P. H., and Kohli, J. D., 1978, A comparison of the vascular dopamine receptor with other dopamine receptors, Annu. Rev. Pharmacol. Toxicol. 18:57–79.

    Article  PubMed  CAS  Google Scholar 

  • Hahn, R. A., and Wardell, J. R., Jr., 1980, Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs, J. Cardiovasc. Pharmacol. 2:583–593.

    Article  PubMed  CAS  Google Scholar 

  • Hahn, R. A., Wardell, J. R., Jr., Sarau, H. M., and Ridley, P. T., 1982, Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist, J. Pharmacol. Exp. Ther. 223:305–313.

    PubMed  CAS  Google Scholar 

  • Hamblin, M. W., and Creese, L, 1982, Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes, Mol. Pharmacol. 21:44–51.

    PubMed  CAS  Google Scholar 

  • Head, R. J., and Berkowitz, B. A., 1979, Radioenzymatic determination of the dopamine, epinephrine and norepinephrine content of the rabbit ear artery, Blood Vessels 16:320–324.

    PubMed  CAS  Google Scholar 

  • Hilditch, A., and Drew, G., 1981, Characteristics of the dopamine receptors in the rabbit isolated splenic artery, Eur. J. Pharmacol. 72:287–296.

    Article  PubMed  CAS  Google Scholar 

  • Holtz, P., and Credner, K., 1942, Die enzymatische Entstehung von Oxytyramin im Organismus und die physiologische Bedeutung der Dopadecarboxylase, Naunyn Schmiedebergs Arch Pharmakol. Exp. Pathol. 200:356–388.

    Article  CAS  Google Scholar 

  • Kohli, J. D., Weder, A. B., Goldberg, L. I., and Ginos, J. Z., 1980, Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors, J. Pharmacol. Exp. Ther. 213:370–374.

    PubMed  CAS  Google Scholar 

  • Langer, S. Z., 1981, Presynaptic regulation of the release of catecholamines, Pharmacol. Rev. 32:337–362.

    Google Scholar 

  • Lokhandwala, M. F., and Jandhyala, B. S., 1979, The role of sympathetic nervous system in the vascular actions of dopamine, J. Pharmacol. Exp. Ther. 210:120–126.

    PubMed  CAS  Google Scholar 

  • McDonald,, R. H., and Goldberg, L. I., 1963, Analysis of the cardiovascular effects of dopamine in the dog, J. Pharmacol. Exp. Ther. 140:60–66.

    CAS  Google Scholar 

  • McNay, J. L., McDonald, R. H., and Goldberg, L. I., 1965, Direct renal vasodilation produced by dopamine in the dog, Circ. Res. 16:510–517.

    Article  PubMed  CAS  Google Scholar 

  • Pendieton, R. G., and Setler, P. E., 1977, Peripheral cardiovascular dopamine receptors, Gen. Pharmacol. 8:1–5.

    Article  Google Scholar 

  • Schmidt, M., and Imbs, J. L., 1980, Pharmacological characterization of renal vascular dopamine receptors, J. Cardiovasc. Pharmacol. 2:595–605.

    Article  PubMed  CAS  Google Scholar 

  • Schmidt, M., Imbs, J.-L., and Schwartz, J., 1979, Effets renaux de la bromocriptine, J. Pharmacol. (Paris) 10:525–532.

    Google Scholar 

  • Schmidt, M., Imbs, J. L., Giesen, E. M., and Schwartz, J., 1982, Vasodilator effects of dopaminomimetics in the perfused rat kidney, Eur. J. Pharmacol. 84:61–70.

    Article  PubMed  CAS  Google Scholar 

  • Schmidt, M., Imbs, J. L., Giesen, E. M., and Schwartz, J., 1983, Blockade of dopamine receptors in the renal vasculature by isomers of flupenthixol and sulpiride, J. Cardiovasc. Pharmacol. 5:86–89.

    Article  PubMed  CAS  Google Scholar 

  • Setler, P. E., Pendieton, R. G., and Finlay, E., 1975, The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs, J. Pharmacol. Exp. Ther. 192:702–712.

    PubMed  CAS  Google Scholar 

  • Toda, N., 1978, Heterogeneity in the relaxation of vascular smooth muscle, in: Mechanisms of Vasodilation (P. M. Vanhoutte and J. Leusen, eds.), Karger, Basel, pp. 129–136.

    Google Scholar 

  • Toda, N., and Goldberg, L. I., 1973, Dopamine induced relaxation of isolated arterials strips, J. Pharm. Pharmacol. 25:587–589.

    Article  PubMed  CAS  Google Scholar 

  • Toda, N., and Hatano, Y., 1979, Antagonism by droperidol of dopamine-induced relaxation in isolated arteries, Eur. J. Pharmacol. 57:231–238.

    Article  PubMed  CAS  Google Scholar 

  • Walton, K. G., Liepmann, P., and Baldessarini, R. J., 1978, Inhibition of dopamine stimulated adenylate cyclase activity by phenoxybenzamine, Eur. J. Pharmacol. 52:231–234.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Smith Kline & French Laboratories, Philadelphia, Pennsylvania, 19101, USA

    Barry A. Berkowitz, Robert Erickson, Bodgan Zabko-Potavpovich & Eliot H. Ohlstein

Authors
  1. Barry A. Berkowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Erickson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bodgan Zabko-Potavpovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eliot H. Ohlstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Smith Kline & French Laboratories, Philadelphia, Pennsylvania, USA

    George Poste  & Stanley T. Crooke  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Berkowitz, B.A., Erickson, R., Zabko-Potavpovich, B., Ohlstein, E.H. (1984). Vascular Dopamine and Dopamine Receptor Agonists. In: Poste, G., Crooke, S.T. (eds) Dopamine Receptor Agonists. New Horizons in Therapeutics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0310-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0310-8_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0312-2

  • Online ISBN: 978-1-4757-0310-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation